faa glp-1 Pilot Minute: Can I take a weight loss drug and still fly? FDA approves first weight-loss GLP-1

Dizziness 7

Following the discovery of semaglutides effectiveness in inducing clinically meaningful weight loss, consumer and clinical demand for GLP-1s increased substantially

The Peptide Therapy Boom Has a Software Problem Peptide therapy is no longer a niche corner of functional medicine

FDA reviewers found no human clinical studies supporting its proposed wound-healing uses

BPC 157, also known as PLD-116, PL-10, PL14736 [9], or Bepectin [10,11,12,13,14,15,16,17], has recently attracted considerable attention as a potential drug candidate that is stable in acidic environments and has no serious adverse effects [18], although it has been known to cause pain and/or necrosis when injected in an aqueous solution or in physiological saline [19]